LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

Search

Champions Oncology Inc

Abierto

SectorSalud

7.11 2.45

Resumen

Variación precio

24h

Actual

Mínimo

6.73

Máximo

7.44

Métricas clave

By Trading Economics

Ingresos

3.8M

4.5M

Ventas

3.6M

17M

P/B

Media del Sector

17.911

50.291

BPA

0.33

Margen de beneficio

26.381

Empleados

210

EBITDA

3.8M

4.9M

Dividendos

By Dow Jones

Próximas Ganancias

10 sept 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-23M

111M

Apertura anterior

4.66

Cierre anterior

7.11

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

154 / 380 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Champions Oncology Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

11 dic 2024, 23:55 UTC

Acciones populares

Stocks to Watch: Adobe, Champions Oncology, DBV Technologies

Comparación entre iguales

Cambio de precio

Champions Oncology Inc Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

5.77 / 7.61Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Very Strong Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

154 / 380 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.